PM-208
The major mechanism of action of PM-208 IV solution in potentially treating severe hypovolemic shock is to increase tissue perfusion to facilitate rapid transfer of oxygen into oxygen-starved tissues and organs. Research suggests that PM 208's biological mechanism is shared by other clinical events associated with traumatic shock including cardiac illness, critical illness, sepsis and vascular disease.
Potential Treatment For:
Hemorrhagic Shock
1.9 M
Annual Lives Lost Worldwide
Traumatic Brain Injury
2.8 M
Injuries Annually US
Potential Treatment For:
Heart Attacks
805 K
Annually US
Congestive Heart Failure
875 K
Hospitalizations Annually US
ICU/ Critical Illness
Potential Treatment For:
Sepsis
1.7 M
Annually US
Acute Respiratory Distress Syndrome
190 K
Annually US
Vascular Disease
Potential Treatment For:
Peripheral Vascular Disease
8.5 M
Cases per year - US
Sickle Cell Crisis
1.2 M
Cases per year - US